灵康药业：灵康控股累计质押公司股票数量约为1.04亿股

Group 1 - The core point of the article is that Lingkang Pharmaceutical has significant shareholding and stock pledge situations, with its controlling shareholder holding 47.09% of the total shares and pledging 30.52% of its holdings [1] - As of the announcement date, Lingkang Pharmaceutical's market capitalization is 4.1 billion yuan [1] - The revenue composition for Lingkang Pharmaceutical for the year 2024 is as follows: 84.62% from pharmaceuticals, 12.19% from pharmaceutical distribution, 2.7% from other businesses, and 0.48% from hospital sales and distribution [1] Group 2 - The controlling shareholder, Lingkang Holdings Group, has pledged approximately 104 million shares, which accounts for 14.37% of the total shares of the company [1] - The company has a total of approximately 340 million unrestricted circulating shares [1]